Special Edition - InFocus: Life Sciences & Healthcare e-newsletter - April 2007
This special edition of our life sciences and healthcare e-newsletter is published to coincide with our sponsorship of Life Science Alliances World 2007 Conference organised by Terrapinn from 16 to 18 April 2007. In this issue we discuss:
- The OFT report on the Pharmaceutical Pricing Regulatory Scheme
- "Best endeavours" and "reasonable endeavours" - What do they mean?
- The private M&A process in the UK
- The ABPI code of practice one year on
Also in this special edition, we include an article "IP valuation in pharmaceuticals and biotech" by our guest writer, Jo Pisani of PricewaterhouseCoopers LLP, as well as details of our recent life science deals.
About Taylor Wessing's Life Sciences & Healthcare Group
Taylor Wessing's market-leading Life Sciences & Healthcare Group provides a top quality, multi-disciplinary service. The Group combines Taylor Wessing’s top-rated intellectual property and venture capital lawyers with specialists from our highly acclaimed international corporate, corporate finance, employment and real estate practices. We advise life sciences and healthcare businesses, those who fund them and those who work for them.
For more information about Taylor Wessing's Life Sciences & Healthcare Group, please click here.
For any legal enquiries, please contact Daniel Pavin or your usual contact at Taylor Wessing. For any marketing and business development enquiries, please contact Sharon Philbey.
Download the complete article (PDF, 342KB)